[e-drug] FOR COVID-19 VACCINES, SOME ARE TOO RICH — AND TOO POOR

e-drug
1

E-DRUG: FOR COVID-19 VACCINES, SOME ARE TOO RICH — AND TOO POOR
---------------------------------------------------------------------

By Matt Apuzzo and Selam Gebrekidan
Published Dec. 28, 2020
Updated Dec. 30, 2020

https://www.nytimes.com/2020/12/28/world/africa/covid-19-vaccines-south-africa.html

Global inequality is shaping which countries get vaccines first. In South Africa, people’s best chance for vaccines anytime soon is to join an experimental trial.

The first year of the Covid-19 pandemic revealed that a country’s wealth would not spare it from the virus. Overconfidence, poor planning and ignored warnings felled some of the world’s richest nations. But now, money is translating into undeniable advantage.

Over the past few months, rich nations like the United States and Britain have cut deals with multiple drug manufacturers and secured enough doses to vaccinate their citizens multiple times over. China and Russia have conducted their own trials and begun mass vaccination programs.

Carinne Bruneton
E-Med@healthnet.org
<carinne.bruneton@hotmail.fr>